Learn / MIRM
NASDAQ: MIRM
Mirum Pharmaceuticals (MIRM) stock, explained like you're 5
Mirum Pharmaceuticals trades on the Nasdaq under the ticker MIRM. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 5.6 billion dollars.
- Ticker
- MIRM
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 5.6 billion dollars
Is Mirum Pharmaceuticals a small, medium or large cap company?
No. Mirum Pharmaceuticals is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 5.6 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Mirum Pharmaceuticals makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves MIRM stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Mirum Pharmaceuticals, Inc. (MIRM) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- Mirum Pharmaceuticals (MIRM) Stock Looks Reasonable After Positive Phase 3 Results (Simply Wall Street)
- Citizens Says FDA’s 'Unexpected' Phase 3 Request Clouds Mirum’s Near Term Outlook MIRM Stock Crashes 15% (Stocktwits)
- Mirum Pharmaceuticals, Inc. (MIRM) stock price, news, quote and history (Yahoo Finance UK)
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Follow MIRM in your daily brief
Each trading day at 5 PM ET we post what happened to Mirum Pharmaceuticals and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow MIRM
Questions about Mirum Pharmaceuticals stock
What does Mirum Pharmaceuticals do?
Mirum Pharmaceuticals trades on the Nasdaq under the ticker MIRM. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 5.6 billion dollars.
What is the ticker symbol for Mirum Pharmaceuticals?
Mirum Pharmaceuticals trades under the ticker MIRM on the Nasdaq.
What is Mirum Pharmaceuticals's market cap?
Mirum Pharmaceuticals is a mid cap stock with a market cap of about 5.6 billion dollars.
How does Mirum Pharmaceuticals make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves MIRM stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow MIRM stock every day?
Add MIRM to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.